不同代的多基化阿达曼坦基的树枝表现出高细胞吸收率,而不会引发细胞毒性
Maxime Grillaud1, Julie Russier, Alberto Bianco
1CNRS, Institut de Biologie Moléculaire et Cellulaire, Immunopathologie et Chimie Thérapeutique , Strasbourg, France.
Journal of the American Chemical Society
|December 21, 2013
概括
研究人员为生物医学应用开发了称为HYDRAmers的新型,无毒的多化树枝. 这些基于阿达曼坦的纳米结构高效地进入细胞,显示了基因和药物输送系统的前景.
科学领域:
- 纳米技术 纳米技术
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 像聚乙烯胺 (PEI) 这样的多化树突体显示出细胞传递的潜力,但往往表现出毒性.
- 这种毒性限制了它们作为基因或药物输送载体的临床应用.
- 需要新的树突纳米结构来克服这些局限性.
研究的目的:
- 设计和合成具有降低细胞毒性的新型多化树 (HYDRAmers).
- 为了评估这些新型树枝的细胞吸收效率.
- 探索它们作为生物医学应用的安全有效纳米载体的潜力.
主要方法:
- 合成第一和第二代基于阿达曼坦的树枝与乙烯糖醇链接剂和氨/瓜尼尼外围群体.
- 对RAW 264.7和HeLa细胞系的细胞毒性评估.
- 细胞内化研究使用5光标签和点击化学.
主要成果:
- 合成的HYDRAmers在测试的细胞系中没有显著的细胞毒性.
- 所有的树枝都表现出高效的细胞吸收,根据世代和外围群体而有所不同.
- 点击化学启用了有效的光标签和跟踪树突内化.
结论:
- 聚化HYDRAmers代表了一个有前途的类别的无毒纳米结构.
- 它们高效的细胞透表明,它们有可能成为基因和药物输送的先进载体.
- 对HYDRAmers的进一步研究可以促进纳米医学的发展.
相关概念视频
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Drug Distribution: Tissue Binding
3.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.7K


